ETCTN 10563: A phase I study of peposertib and liposomal doxorubicin for advanced or metastatic leiomyosarcoma and other sarcomas. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.

During a live event, Gary J. Schiller, MD, reviewed the diagnostics and characteristics of blastic plasmacytoid dendritic ...

Telesis Bio has announced a licensing agreement with Regeneron, enabling the latter to deploy the Gibson SOLA platform at R&D ...

Popular actor Dipika Kakkar has revealed her stage 2 liver cancer diagnosis. Following hospitalisation for persistent pain, ...